Home » J&J Working to Boost Supply of Cancer Drug Doxil by September
J&J Working to Boost Supply of Cancer Drug Doxil by September
Johnson & Johnson said it’s exploring ways to resume making the cancer medicine Doxil by September after a production shutdown at a supplier last year contributed to a shortage.
Businessweek
Businessweek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May